| Mind-Body Health in Uro-Oncology: Research Study (NCT03852030) | Northwestern University | 2012-07-01 |
| Studying Biomarkers in Samples From Younger Patients With Wilms Tumor (NCT01576198) | Children's Oncology Group | 2012-04-01 |
| Studying Genes Using Cord Blood and Placenta Samples From Relatively Healthy Newborns and Samples From Younger Patients With Wilms Tumor (NCT01576211) | Children's Oncology Group | 2012-04-01 |
| Studying Gene Expression in Samples From Patients With Rhabdoid Tumors (NCT01553175) | Children's Oncology Group | 2012-03-01 |
| Studying Biomarkers in Samples From Young Patients With Rhabdoid Tumors (NCT01544569) | Children's Oncology Group | 2012-03-01 |
| Biomarkers in Urine Samples From Patients With Wilms Tumor (NCT01550393) | Children's Oncology Group | 2012-03-01 |
| Hydroxyethyl Starch and Renal Function After Laparoscopic Nephrectomy (NCT01486550) | Regional Hospital Holstebro | 2011-12-01 |
| UroCCR Database: French Research Network for Kidney Cancer -UroCCR (NCT03293563) | University Hospital, Bordeaux | 2011-12-01 |
| Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor (NCT01314391) | Children's Oncology Group | 2011-08-01 |
| Assessing Everolimus in Fist Line Treatment on Patients With Metastatic Kidney Cancer (NCT01888042) | Gustave Roussy, Cancer Campus, Grand Paris | 2011-07-01 |
| Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer (NCT01353300) | Children's Oncology Group | 2011-05-01 |
| S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery (NCT01120249) | SWOG Cancer Research Network | 2011-04-01 |
| Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal (NCT00831480) | Linda C. Higgins | 2011-04-01 |
| Neoadjuvant Axitinib in Locally Advanced Renal Cell Carcinoma (RCC) (NCT01263769) | M.D. Anderson Cancer Center | 2011-02-01 |
| Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial (NCT01217931) | M.D. Anderson Cancer Center | 2011-01-19 |
| Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell Carcinoma (NCT01264341) | Hellenic Cooperative Oncology Group | 2010-12-01 |
| Sunitinib Malate With or Without Gemcitabine Hydrochloride in Treating Patients With Advanced Kidney Cancer That Cannot Be Removed By Surgery (NCT01164228) | ECOG-ACRIN Cancer Research Group | 2010-09-17 |
| Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma (NCT01185366) | M.D. Anderson Cancer Center | 2010-08-01 |
| Cardiac Arrhythmias in Patients Undergoing Kidney Cancer Surgery Depending on the Anaesthesia Method (NCT02988219) | Medical University of Warsaw | 2010-06-01 |
| Sunitinib Plus Temsirolimus in Patients With Renal Cell Cancer (RCC) (NCT01122615) | M.D. Anderson Cancer Center | 2010-05-01 |
| Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (NCT01099423) | European Organisation for Research and Treatment of Cancer - EORTC | 2010-04-01 |
| Study of Pazopanib and Ixabepilone in Patients With Solid Tumors (NCT01012362) | Masonic Cancer Center, University of Minnesota | 2009-12-01 |
| Determining the Lymphokine Activated Killer (LAK) Cytotoxicity Present in Patients Undergoing Interleukin-2 Therapy (NCT01068470) | Loma Linda University | 2009-11-01 |
| Biomarkers in Tumor Tissue Samples From Young Patients With Very Low Risk Wilms Tumors (NCT01004783) | Children's Oncology Group | 2009-10-01 |
| Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features (NCT01048892) | Children's Oncology Group | 2009-09-01 |
| 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors (NCT00967577) | Weill Medical College of Cornell University | 2009-07-01 |
| Acceptability of Less Harmful Alternatives to Cigarettes (NCT00957424) | Roswell Park Cancer Institute | 2009-06-01 |
| Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma (NCT00782275) | Beth Israel Deaconess Medical Center | 2009-04-01 |
| Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 Receptor (NCT00923390) | National Cancer Institute (NCI) | 2009-03-02 |
| Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer (NCT00853125) | Rutgers, The State University of New Jersey | 2009-02-01 |
| Sunitinib Malate in Treating Patients With Kidney Cancer (NCT00943839) | Centre Antoine Lacassagne | 2009-02-01 |
| Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery (NCT00747305) | Harry Drabkin | 2008-10-01 |
| Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors (NCT00788125) | City of Hope Medical Center | 2008-09-03 |
| Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking (NCT00790569) | Butler Hospital | 2008-09-01 |
| Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases (NCT00769990) | Masonic Cancer Center, University of Minnesota | 2008-09-01 |
| Warm Ischemia or Cold Ischemia During Surgery in Treating Patients With Stage I Kidney Cancer (NCT00743236) | Wake Forest University Health Sciences | 2008-08-01 |
| Sorafenib in Treating Patients With Locally Advanced or Metastatic Kidney Cancer (NCT00727532) | Northwestern University | 2008-07-01 |
| Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer (NCT00806650) | City of Hope Medical Center | 2008-07-01 |
| Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors (NCT00722228) | Hadassah Medical Organization | 2008-07-01 |
| Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer (NCT00704938) | National Institutes of Health Clinical Center (CC) | 2008-06-01 |
| Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer (NCT00717587) | Abramson Cancer Center at Penn Medicine | 2008-06-01 |
| Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer (NCT00908739) | Case Comprehensive Cancer Center | 2008-05-01 |
| Cancer Development In Organ Transplant Recipients (NCT02333279) | University of Zurich | 2008-05-01 |
| MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney Cancer (NCT00873236) | Mount Vernon Cancer Centre at Mount Vernon Hospital | 2008-04-01 |
| Study of MDX-1411 Given Every 14 Days With Pre-medications to Subjects With Clear Cell Kidney Cancer. (NCT00656734) | Bristol-Myers Squibb | 2008-04-01 |
| Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma (NCT00659568) | London Health Sciences Centre | 2008-03-01 |
| Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast (NCT00671411) | Memorial Sloan Kettering Cancer Center | 2008-03-01 |
| Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody (NCT00606632) | Heidelberg Pharma AG | 2008-03-01 |
| Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases (NCT00540969) | Alliance for Clinical Trials in Oncology | 2008-02-01 |
| PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer (NCT00589550) | Thomas Olencki | 2008-02-01 |
| Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom (NCT00757614) | Cancer Research UK | 2008-02-01 |
| Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer (NCT00601926) | Paul Monk | 2008-02-01 |
| A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886) (NCT00600496) | AstraZeneca | 2007-12-14 |
| Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer (NCT00854620) | Stanford University | 2007-12-01 |
| Ultrasound in Assessing Antiangiogenic Treatment in Patients With Advanced Kidney Cancer (NCT01105364) | National Cancer Institute, France | 2007-12-01 |
| Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma (NCT00617799) | University of Nebraska | 2007-10-02 |
| Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain (NCT00550654) | National Institutes of Health Clinical Center (CC) | 2007-10-01 |
| Sunitinib as First-Line Therapy in Treating Patients With Locally Advanced Metastatic Papillary Renal Cell Cancer (NCT00541008) | UNICANCER | 2007-09-05 |
| Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy (NCT00896467) | Centre Oscar Lambret | 2007-09-01 |
| Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer (NCT00849186) | Roswell Park Cancer Institute | 2007-08-01 |
| Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney Cancer (NCT01024205) | Barts and the London School of Medicine and Dentistry | 2007-08-01 |
| Ph II Study of Perifosine for Patients With Carcinoma of the Kidney (NCT00498966) | AEterna Zentaris | 2007-07-01 |
| Capecitabine, Gemcitabine, and Bevacizumab in Combination for Patients With Sarcomatoid Renal Cell Carcinoma (NCT00496587) | M.D. Anderson Cancer Center | 2007-07-01 |
| Sorafenib in Treating Patients at Risk of Relapse After Undergoing Surgery to Remove Kidney Cancer (NCT00492258) | Medical Research Council | 2007-06-01 |
| Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer (NCT00369564) | University of South Florida | 2007-05-01 |
| Interleukin-7 in Treating Patients With Metastatic Melanoma or Locally Advanced or Metastatic Kidney Cancer (NCT00492440) | Cytheris SA | 2007-05-01 |
| Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer (NCT00787761) | Northside Hospital, Inc. | 2007-04-01 |
| Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer (NCT00465179) | M.D. Anderson Cancer Center | 2007-03-01 |
| Sorafenib in Treating Patients With Metastatic or Unresectable Kidney Cancer (NCT00496756) | University of Nebraska | 2007-03-01 |
| Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors (NCT00620295) | Masonic Cancer Center, University of Minnesota | 2007-03-01 |
| Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer (NCT00459875) | Memorial Sloan Kettering Cancer Center | 2007-03-01 |
| Sunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or Melanoma (NCT00462982) | Memorial Sloan Kettering Cancer Center | 2007-03-01 |
| Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery (NCT00459979) | Case Comprehensive Cancer Center | 2007-03-01 |
| Radiosurgery in Treating Patients With Kidney Tumors (NCT00458484) | Case Comprehensive Cancer Center | 2007-02-20 |
| High-dose Bevacizumab in Advanced Renal Carcinoma Patients (NCT00455975) | SCRI Development Innovations, LLC | 2007-02-01 |
| Stereotactic Radiation Therapy in Treating Patients With Kidney Tumors (NCT00445757) | Case Comprehensive Cancer Center | 2007-01-01 |
| Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer (NCT00436410) | National Institutes of Health Clinical Center (CC) | 2006-12-01 |
| Talabostat in Treating Patients With Metastatic Kidney Cancer (NCT00489710) | University of Nebraska | 2006-12-01 |
| Sorafenib in Treating Patients Undergoing Surgery for Stage II, Stage III, or Stage IV Kidney Cancer (NCT00405366) | UNC Lineberger Comprehensive Cancer Center | 2006-11-01 |
| A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma (NCT00422344) | Memorial Sloan Kettering Cancer Center | 2006-10-01 |
| Zoledronate With Atorvastatin in Renal Cell Carcinoma (NCT00490698) | M.D. Anderson Cancer Center | 2006-10-01 |
| Sunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney Cancer (NCT00425386) | OHSU Knight Cancer Institute | 2006-08-01 |
| Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants (NCT00900276) | Wake Forest University Health Sciences | 2006-06-01 |
| Paclitaxel and Carboplatin in Treating Patients With Locally Advanced or Metastatic Renal Cell Cancer (NCT00077129) | Eastern Cooperative Oncology Group | 2006-06-01 |
| Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma (NCT00323739) | SCRI Development Innovations, LLC | 2006-05-01 |
| Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial (NCT00316901) | National Institutes of Health Clinical Center (CC) | 2006-04-01 |
| Bortezomib in Treating Patients With Metastatic Kidney Cancer (NCT00276614) | Jonsson Comprehensive Cancer Center | 2006-04-01 |
| Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer (NCT00323791) | University of Medicine and Dentistry of New Jersey | 2006-04-01 |
| A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients (NCT00421512) | Memorial Sloan Kettering Cancer Center | 2006-03-01 |
| Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors (NCT00624962) | Vanderbilt University | 2006-03-01 |
| Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking (NCT00365508) | Fox Chase Cancer Center | 2006-02-01 |
| Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab (NCT00866320) | Case Comprehensive Cancer Center | 2006-02-01 |
| Bupropion in Helping Adults Stop Smoking (NCT00534001) | Roswell Park Cancer Institute | 2006-01-01 |
| Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases (NCT00588913) | Tokyo Women's Medical University | 2006-01-01 |
| Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer (NCT00514215) | Barbara Ann Karmanos Cancer Institute | 2006-01-01 |
| Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer (NCT00331409) | OHSU Knight Cancer Institute | 2006-01-01 |
| Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery (NCT00293501) | University of Vermont | 2005-12-01 |
| Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney (NCT00853021) | Jorge A. Garcia, MD | 2005-12-01 |
| Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors (NCT00303940) | National Institutes of Health Clinical Center (CC) | 2005-12-01 |
| Sorafenib in Treating Patients With Kidney Cancer That Has Spread to the Brain (NCT00301847) | National Cancer Institute (NCI) | 2005-11-01 |